Sonomax Grants Stock Options to Align Focus on V4
The exercise price of the stock options is
Sonomax also announces that it has cancelled stock options held by an aggregate of four non-executive employees and eight consultants, including one investor-relations consultant, in respect of an aggregate of 2,510,000 common shares. The cancelled stock options had exercise prices ranging from
About the New Sonomax:
Sonomax is an R&D and licensing company of in-ear technologies. The Company's patented instant custom-fitting earpieces deliver the most comfortable sound-enhancing earpieces in the world. This unique technology enables a wide range of applications such as earphones for the music and gaming markets, hearing protection for military and industrial applications, affordable hearing aids and the ever-expanding Bluetooth(TM) headset market.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
%SEDAR: 00013736EFor further information: Nick Laperle, President and CEO, Sonomax Hearing Healthcare Inc., (514) 932-2674, firstname.lastname@example.org